خلاصہ: F.D.A. Sharply Limits Approval for Drug Linked to Two Teen Deaths
The drug Elevidys has been central to the business model of Sarepta Therapeutics, a publicly traded company that is worth about $2 billion.

خلاصہ: F.D.A. Sharply Limits Approval for Drug Linked to Two Teen Deaths
